Scientific Industries INC: management transactions · United States · SEC (Form 4)

About Scientific Industries INC

Scientific Industries Inc. (SCND) is a U.S.-based life science technology company focused on laboratory instrumentation, pharmacy automation, and bioprocessing. Although your prompt references NYSE/NASDAQ, the public sources reviewed indicate the shares are currently quoted on OTCQB rather than listed on NYSE or NASDAQ. The company is headquartered in Bohemia, New York, United States, and also maintains operations in Europe. Founded in 1954, Scientific Industries built its legacy in benchtop laboratory equipment before executing a major strategic refocus in 2025 toward two growth platforms: pharmacy automation and bioprocessing.([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai)) Historically, the company was best known for its mixing and agitation products, particularly the Vortex-Genie family, as well as precision weighing and measurement products sold under the Torbal brand. That heritage gave Scientific Industries a durable presence in university, hospital, pharmaceutical, and industrial laboratories. Even after selling its Genie division in August 2025, the company still retains a strong identity in precision science tools and workflow-enabling lab technologies.([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai)) Today, Scientific Industries is organized around two core operating themes. The first is pharmacy automation, led by VIVID® automated pill counting systems and related workstation solutions designed to improve dispensing speed, accuracy, and compliance. The second is bioprocessing, through Scientific Bioprocessing (SBI) and its DOTS® platform, which is intended to generate high-density experimental data early in development and help researchers reduce scale-up risk. The company also highlights precision scales, laboratory balances, and moisture analyzers under Torbal, supporting its broader presence in regulated scientific workflows.([scientificindustries.com](https://www.scientificindustries.com/pages/about-us?utm_source=openai)) From a competitive standpoint, Scientific Industries is best viewed as a niche specialist rather than a broad-based industrial giant. Its value proposition rests on application-specific products, embedded workflow intelligence, and the ability to serve regulated end markets where accuracy, repeatability, and data quality matter. In bioprocessing, the differentiator is the promise of richer, more actionable data earlier in the development cycle; in pharmacy automation, the emphasis is on compliance and operational efficiency. The company also points to a long-standing installed base and patented technologies, which can support customer retention and product credibility despite its smaller scale relative to larger peers.([scientificindustries.com](https://www.scientificindustries.com/pages/about-us?utm_source=openai)) Geographically, Scientific Industries remains anchored in the United States, with its headquarters in Bohemia, New York, and additional operational references in Pittsburgh and Germany in its SEC filings. Its products are sold globally through both distributors and direct sales channels, depending on the product family. Recent corporate milestones include new funding for SBI in April 2025, fiscal-year 2024 and first-quarter 2025 reporting, and the August 2025 divestiture of the Genie division for approximately $9.6 million in cash, plus a potential earnout, which materially sharpened the company’s strategic focus on data-driven platforms.([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai))